CannonP. J., SymchychP. S., DemartiniF. E.: The distribution of urate in human and primate kidney. Proc. Soc. Exp. Biol. Med., 129; 278–283 (1968).
2.
EpsteinF. H., PigeonG.: Experimental urate nephropathy: studies of the distribution of urate in renal tissue. Nephron, 1; 144–157 (1964).
3.
FanelliG. M.Jr., WfinerI. M.: Pirazinoate excretion in the chimpanzee; relation to urate disposition and the actions of uricosuric drugs. J. Clin. Invest., 52; 1946–1957 (1973).
4.
MayD. G., WfinerI. M.: Bidirectional active transport of m-hydroxybenzoate in proximal tubules in dogs. Amer. J. Physiol., 218; 430–436 (1970).
5.
MayD. G., WeinerI. M.: The renal mechanisms for the excretion of m-hydroxybenzoic acid in Cebus Monkeys: relationship to urate transport. J. Pharmac. Exp. Ther., 176; 407–417 (1971).
6.
PiccinnoA., ZottiD., BrunoL., Siro-BrigianiG., PagliaruloA.: Contributo sperimentale allo studio della litolisi vescicale in varie condizioni sperimentali. Urologia, 40; 517–529 (1973).
7.
TannerG. A., KinterW. B.: Re-absorption and secretion of p-aminohippurate and diodrast in Necturus kidney. Amer. J. Physiol., 210; 221–231 (1966).
8.
WeinerJ. M., TinkerJ. P.: Pharmacology of pyrazinamide. Metabolic and renal function studies related to the mechanism of drug induced urate retention. J. Pharmac. Exp. Ther., 180; 411–434 (1972).
9.
YüT. F., GutmanA. B.: Study of the paradoxical effects of salycilate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J. Clin. Invest., 38; 1298–1315 (1959).
